Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

56%

5 trials in Phase 3/4

Results Transparency

50%

4 of 8 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 3

5(55.6%)

Phase 2

2(22.2%)

Phase 1

2(22.2%)

9Total

Phase 3(5)

Phase 2(2)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04756804Phase 3Completed

Perioperative Patient Skin Antiseptic Preparation Evaluation

Role: lead

NCT02831998Phase 3Completed

In-vivo Efficacy of Patient Preoperative Prep

Role: lead

NCT03782103Phase 3Completed

In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP)

Role: lead

NCT02831816Phase 3Completed

Clinical Evaluation of Patient Preoperative Prep

Role: lead

NCT02578771Phase 3Completed

Pilot Clinical Evaluation to Characterize in Vivo Effects of Topically Applied ZuraPrep & ZuraPrep Vehicle

Role: lead

NCT02221232Phase 2Terminated

Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™

Role: lead

NCT02296645Phase 2Completed

Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)

Role: lead

NCT02160587Phase 1Completed

Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

Role: lead

NCT02160574Phase 1Completed

Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

Role: lead

All 9 trials loaded